Marko M Hyytiäinen (Marko Hyytiäinen, Marko Hyytiainen)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 4

Top Topics

Oxide Nanoparticles

Induced Apoptosis

Diffuse Large B Cell Lymphoma

Chronic Myeloid Leukemia

Top Venues

Blood cancer discovery

Journal of experimental & clinical cancer research : CR

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Leo Meriranta, Selma Sorri, Kanutte Huse, Xiaonan Liu, Ivana Spasevska, Sadia Zafar, Iftekhar Chowdury, Olli Dufva, Eerika Sahlberg, Luka Tandaric, Marja-Liisa Karjalainen-Lindsberg, Marko M Hyytiäinen, Markku Varjosalo, June Helen Myklebust, Sirpa Leppa
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma. Blood cancer discovery 5 (5) (2024)
Leo Meriranta, Selma Sorri, Kanutte Huse, Xiaonan Liu, Ivana Spasevska, Sadia Zafar, Iftekhar Chowdury, Olli Dufva, Eerika Sahlberg, Luka Tandaric, Marja-Liisa Karjalainen-Lindsberg, Marko M Hyytiäinen, Markku Varjosalo, June Helen Myklebust, Sirpa Leppa
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-cell Lymphoma. Blood cancer discovery (2024)
Hector J Monzo, Kerttu Kalander, Marko M Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas J J Jukonen, Pirjo Laakkonen, Ari Ristimäki, Joseph W Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund, Hanna Seppänen, Sirpa Leppa, Päivi M Ojala
Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model. Molecular cancer therapeutics (2023)
Irene Ylivinkka, Harri Sihto, Olli Tynninen, Yizhou Hu, Aki Laakso, Riku Kivisaari, Pirjo Laakkonen, Jorma Keski-Oja, Marko M Hyytiäinen
Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness. Journal of experimental & clinical cancer research : CR 36 (1) (2017)